Nuclea Biotechnologies' intellectual property will be sold at auction in January.
Heritage Global Partners will auction the material online globally on Jan. 18. The sale includes the licensing, patents, and materials for the various diagnostic tests the company developed. The auction is part of the bankruptcy proceedings, which the company filed for earlier this year.
PEDA is looking to recoup some $10,000 in losses from Nuclea Biotechnologies, Inc, which has filed for Chapter bankruptcy.
Nuclea had rented office space the from the Pittsfield Economic Development Authority on Kellogg Street for a number of years. That lease agreement was until the end of October this year.